AI Article Synopsis

  • Generalized pustular psoriasis (GPP) is characterized by non-acral primary sterile pustules and can flare up due to triggers like medications, stress, or viral infections.
  • A case study discusses a 45-year-old male with a background of spondyloarthropathy who experienced a new pustular rash after a COVID-19 infection while on a tumor necrosis factor-α inhibitor.
  • The text highlights the need to investigate how infections and biologic treatments interact in the context of GPP flare-ups.

Article Abstract

Generalized pustular psoriasis (GPP) is a form of pustular psoriasis that is distinguished by recurring or persistent outbreaks of non-acral primary sterile pustules. These eruptions can occur with or without systemic inflammation. Various factors, such as medications, stress and viral infection, have been identified as potential triggers for GPP flares. While several cases have detailed GPP-like eruptions in the setting of coronavirus disease 2019 (COVID-19) infection, few have explored the interplay between infection and biologic use in the development of GPP. In this case, we detail the history and management of a 45-year-old male patient with a prior history of spondyloarthropathy managed on a tumour necrosis factor-α inhibitor and recent COVID-19 infection presenting with a new, spreading pustular rash.

Download full-text PDF

Source
http://dx.doi.org/10.1111/exd.14889DOI Listing

Publication Analysis

Top Keywords

covid-19 infection
12
generalized pustular
8
pustular psoriasis
8
infection
5
pustular psoriasis-like
4
psoriasis-like widespread
4
widespread eruption
4
eruption covid-19
4
infection patient
4
patient spondyloarthropathy
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!